Search

everythinglearnresearchcommunity

for

Search:↓

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

HB24 helps convert IBA to IAA, promoting root hair growth.

People with alopecia areata have higher insulin resistance.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

AI is now essential in Indian aesthetic medicine.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

People with alopecia areata may have a higher risk of hearing loss.

THA is a rare condition with no significant clinical consequences if thyroid function is normal.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Coudability hairs are useful markers for alopecia areata activity.

Hair loss in young men in Central India is linked to severe heart disease.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Both HLA-B and MICA are independently linked to alopecia areata.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

SII is a useful and affordable tool to assess and monitor alopecia areata.

AI improves biomaterial design by making it faster, cheaper, and more effective for personalized medicine.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Mouse models help understand alopecia areata and find treatments.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.